Acute Subcutaneous Defibrillation
ASQ
1 other identifier
observational
50
5 countries
8
Brief Summary
To assess the defibrillation efficacy of a subcutaneous defibrillation system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2013
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2013
CompletedFirst Posted
Study publicly available on registry
January 18, 2013
CompletedStudy Start
First participant enrolled
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedResults Posted
Study results publicly available
December 2, 2016
CompletedDecember 2, 2016
October 1, 2016
1 year
January 16, 2013
October 10, 2016
October 10, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Subjects Will Demonstrate a Successful Defibrillation Outcome if They Have 2 Successful Defibrillation Shocks With the Research System.
within the first day
Eligibility Criteria
Subjects may be either male or female, and must meet all of the inclusion criteria and none of the exclusion criteria of the study
You may qualify if:
- Subject must be undergoing implant of a commercially approved ICD system
- Subject must be willing to provide Informed Consent
- Subject must be \> 18 years old
You may not qualify if:
- Subject with impaired kidney function as measured by a glomerular filtration rate (eGFR) estimate \< 29 mls/min/1.73m2 (recorded in the last six months)
- Subject has high risk of infection
- Subject has EF \< 15%
- Subject at high risk of stroke
- having a device replacement
- Subject with an implanted active non-ICD device, cardiac or non-cardiac (e.g., Neuro stimulator, Pacemaker)
- Subject is indicated for CRT
- Subject is pacemaker dependent
- Subject enrolled in a concurrent study that may confound the results of this study
- Subject has medical conditions that would limit study participation
- Subject is pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Republican Scientific and Practical Center Cardiology
Minsk, Belarus
Rigshospitalet
Copenhagen, Denmark
St. Antonius Ziekenhuis
Nieuwegein, Netherlands
Erasmus MC
Rotterdam, Netherlands
Slovak Medical University
Bratislava, Slovakia, 83348, Slovakia
Dudley Group NHS-Russells Hall Hospital
Dudley, United Kingdom
King's College Hospital
London, United Kingdom
Southhampton General Hospital
Southhampton, United Kingdom
Results Point of Contact
- Title
- Medtronic CRDM Clinical Trial Manager
- Organization
- Medtronic, Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 16, 2013
First Posted
January 18, 2013
Study Start
May 1, 2013
Primary Completion
May 1, 2014
Study Completion
June 1, 2014
Last Updated
December 2, 2016
Results First Posted
December 2, 2016
Record last verified: 2016-10